"Medicina Reproductiva diseñada a su medida."

During the past decade, Instituto Bernabeu conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto Bernabeu" #1 sponsor was "Instituto Bernabeu" with 10 trials, followed by "IBSA Institut Biochimique SA" with 1 trials sponsored, "OXOLIFE" with 1 trials sponsored, "Peter Humaidan" with 1 trials sponsored and "Rafael Bernabeu Pérez" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Bernabeu" #1 collaborator was "Instituto Bernabeu" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Bernabeu" are "Infertility" (4 trials), "Reproductive Techniques, Assisted" (2 trials), "Abnormality" (1 trials), "Bacterial Vaginoses" (1 trials) and "Chromosome Abnormality" (1 trials). Many other conditions were trialed in "Instituto Bernabeu" in a lesser frequency.

Most popular intervention types in "Instituto Bernabeu" are "Drug" (8 trials), "Other" (3 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Decapeptyl 0.1 mg® (a-GnRH) and Ovitrelle® (hCG) used together" (1 trials), "Embryo observation" (1 trials), "Follicular phase" (1 trials), "GnRH agonist" (1 trials) and "GnRH antagonist" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Bernabeu" are 13 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Instituto Bernabeu". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Instituto Bernabeu, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Bernabeu, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 4 trials that are defined as “Not Applicable".